MedPath

A Randomized Trial to Evaluate the Effectiveness of Transferring the Flexor Hallucis Longus Tendon

Phase 4
Conditions
Achilles Tendinopathy
Interventions
Procedure: Transfer of the Flexor Hallucis Longus Tendon
Procedure: Flexor Hallucis Longus Tendon transfer
Procedure: No transfer of Flexor Hallucis Longus tendon
Registration Number
NCT01341509
Lead Sponsor
OAD Orthopaedics
Brief Summary

The optimal surgical treatment for insertional Achilles tendinopathy remains unclear. The purpose of this study is to evaluate the long-term outcome of surgical treatment by comparing the patient reported outcomes of Insertional Achilles Tendinopathy; Achilles tendon debridement, excision calcaneal exostosis, Strayer procedure, secondary repair of Achilles with flexor hallucis longus (FHL) transfer and Achilles tendon debridement, excision calcaneal exostosis, Strayer procedure, secondary repair of Achilles without FHL transfer.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Male and female 18 years or older

  • Diagnosed with insertional Achilles tendinosis by history and physical exam

  • Confirmed by x-ray and MRI

  • Calcification at the Achilles insertion and gastrocnemius tightness.

  • Failure of the following non-operative treatment for greater than 6 months: *shoe modifications

    • physical therapy
    • immobilization
    • and home exercise program.
  • In addition, participant must have an intact flexor hallucis longus tendon.

Exclusion Criteria
  • Patients who have failed surgery for the same and patients with diabetic neuropathy.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
FHL tendon transferredTransfer of the Flexor Hallucis Longus TendonSurgical group in which the FHL tendon was transferred
FHL tendon not transferredFlexor Hallucis Longus Tendon transfer-
FHL tendon not transferredNo transfer of Flexor Hallucis Longus tendon-
Primary Outcome Measures
NameTimeMethod
Statistical difference2 years

To detect a 20% difference in clinical outcomes between the two surgical groups.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

OAD Orthopaedics

🇺🇸

Warrenville, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath